Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M De Haan

Showing results (191-200 of 284) with videos related to

Pageof 29
Sort By:
Gene Therapy|April 22, 2005
Targeting non-human coronaviruses to human cancer cells using a bispecific single-chain antibodyT Würdinger, M H Verheije, M Raaben, et al.
Archives of Otolaryngology--Head & Neck Surgery|May 1, 1986
Defective monocyte chemotaxis in patients with head and neck cancer. Restoration after treatmentI B Tan, H A Drexhage, R J Scheper, et al.
Virology|August 16, 2003
The glycosylation status of the murine hepatitis coronavirus M protein affects the interferogenic capacity of the virus in vitro and its ability to replicate in the liver but not the brainCornelis A M de Haan, Marèl de Wit, Lili Kuo, et al.
Plos Pathogens|June 14, 2008
Mouse hepatitis coronavirus RNA replication depends on GBF1-mediated ARF1 activationMonique H Verheije, Matthijs Raaben, Muriel Mari, et al.
Biomaterials and Biosystems|February 24, 2023
Natural language processing in toxicology: Delineating adverse outcome pathways and guiding the application of new approach methodologiesMarie P F Corradi, Alyanne M de Haan, Bernard Staumont, et al.
Methods in Molecular Biology (Clifton, N.J.)|February 28, 2015
A field-proven yeast two-hybrid protocol used to identify coronavirus-host protein-protein interactionsPierre-Olivier Vidalain, Yves Jacob, Marne C Hagemeijer, et al.
American Journal of Respiratory and Critical Care Medicine|March 3, 2015
Impaired Antibody-mediated Protection and Defective IgA B-Cell Memory in Experimental Infection of Adults with Respiratory Syncytial VirusMaximillian S Habibi, Agnieszka Jozwik, Spyridon Makris, et al.
Iscience|June 9, 2025
Cell-based sialoglycan arrays for directly comparing influenza A virus receptor requirements for binding and infectionMengying Liu, Xuesheng Wu, Martijn D B van de Garde, et al.
Journal of Virology|December 14, 2007
Coronavirus escape from heptad repeat 2 (HR2)-derived peptide entry inhibition as a result of mutations in the HR1 domain of the spike fusion proteinBerend Jan Bosch, John W A Rossen, Willem Bartelink, et al.
Plos One|August 17, 2013
A protective and safe intranasal RSV vaccine based on a recombinant prefusion-like form of the F protein bound to bacterium-like particlesAlan Rigter, Ivy Widjaja, Hanneke Versantvoort, et al.
Pageof 29

Showing results (191-200 of 284) with videos related to

Sort By:
Pageof 29
Gene Therapy|April 22, 2005
Targeting non-human coronaviruses to human cancer cells using a bispecific single-chain antibodyT Würdinger, M H Verheije, M Raaben, et al.
Archives of Otolaryngology--Head & Neck Surgery|May 1, 1986
Defective monocyte chemotaxis in patients with head and neck cancer. Restoration after treatmentI B Tan, H A Drexhage, R J Scheper, et al.
Virology|August 16, 2003
The glycosylation status of the murine hepatitis coronavirus M protein affects the interferogenic capacity of the virus in vitro and its ability to replicate in the liver but not the brainCornelis A M de Haan, Marèl de Wit, Lili Kuo, et al.
Plos Pathogens|June 14, 2008
Mouse hepatitis coronavirus RNA replication depends on GBF1-mediated ARF1 activationMonique H Verheije, Matthijs Raaben, Muriel Mari, et al.
Biomaterials and Biosystems|February 24, 2023
Natural language processing in toxicology: Delineating adverse outcome pathways and guiding the application of new approach methodologiesMarie P F Corradi, Alyanne M de Haan, Bernard Staumont, et al.
Methods in Molecular Biology (Clifton, N.J.)|February 28, 2015
A field-proven yeast two-hybrid protocol used to identify coronavirus-host protein-protein interactionsPierre-Olivier Vidalain, Yves Jacob, Marne C Hagemeijer, et al.
American Journal of Respiratory and Critical Care Medicine|March 3, 2015
Impaired Antibody-mediated Protection and Defective IgA B-Cell Memory in Experimental Infection of Adults with Respiratory Syncytial VirusMaximillian S Habibi, Agnieszka Jozwik, Spyridon Makris, et al.
Iscience|June 9, 2025
Cell-based sialoglycan arrays for directly comparing influenza A virus receptor requirements for binding and infectionMengying Liu, Xuesheng Wu, Martijn D B van de Garde, et al.
Journal of Virology|December 14, 2007
Coronavirus escape from heptad repeat 2 (HR2)-derived peptide entry inhibition as a result of mutations in the HR1 domain of the spike fusion proteinBerend Jan Bosch, John W A Rossen, Willem Bartelink, et al.
Plos One|August 17, 2013
A protective and safe intranasal RSV vaccine based on a recombinant prefusion-like form of the F protein bound to bacterium-like particlesAlan Rigter, Ivy Widjaja, Hanneke Versantvoort, et al.
Pageof 29